SCYNEXIS, Inc. Executive Officer Compensation Approval (2016 Bonuses, 2017 Salaries, and Stock Options)

Summary

SCYNEXIS, Inc.'s Board of Directors approved compensation for its executive officers, including Marco Taglietti (CEO), David Angulo (CMO), and Eric Francois (CFO). The agreement covers cash bonuses for 2016, new salaries effective March 1, 2017, and stock option grants under the company's 2014 Equity Incentive Plan. The stock options vest monthly over four years, provided the officers remain with the company. This document outlines the amounts and terms for each officer's compensation.

EX-10.34 3 exhibit1034.htm EXHIBIT 10.34 Exhibit


Exhibit 10.34
On January 31, 2017, the Board of Directors of SCYNEXIS, Inc. took the following compensation actions with respect to SCYNEXIS’s following executive officers (collectively, the “Officers”):
2016 Officer Bonuses
Approved cash bonuses for the Officers based on SCYNEXIS’s performance for the calendar year 2016:
Executive Officer
 
Title


Bonus
Marco Taglietti, M.D.
 
Chief Executive Officer
 
$210,100
David Angulo, M.D.
 
Chief Medical Officer
 
$136,600
Eric Francois
 
Chief Financial Officer
 
$113,000

2017 Salaries

Approved the 2017 salaries for the Officers, to be effective March 1, 2017, as follows:
Executive Officer
 
Title


2017 Salary
Marco Taglietti, M.D.
 
Chief Executive Officer
 
$510,000
David Angulo, M.D.
 
Chief Medical Officer
 
$413,800
Eric Francois
 
Chief Financial Officer
 
$360,500

Option Grants
Approved stock option grants under SCYNEXIS 's 2014 Equity Incentive Plan to the following Officers:
Executive Officer
 
Title


Shares subject to Option
Marco Taglietti, M.D.
 
Chief Executive Officer
 
360,000
David Angulo, M.D.
 
Chief Medical Officer
 
140,000
Eric Francois
 
Chief Financial Officer
 
100,000

The options have an exercise price of $3.02 per share and vest on a monthly basis over a four-year period, provided such officer is continuing to provide services to SCYNEXIS on such vesting date.